Additional file 3 of IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation

Additional file 3: Table 1. Clinical-pathological features and Tumor mutational burden of 39 GBMs enriched in giant cells. Cases are sorted by ID number. Table 2: List of somatic and germline mutations identified in all samples. Table 3. MMR mutations, MMR immunohistochemistry, MSI and TMB in 39 giant cell enriched GBMs. Cases are arranged by TMB.